967 results on '"van Kooyk, Yvette"'
Search Results
2. The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
3. The transcriptional landscape of glycosylation-related genes in cancer
4. Targeting myeloid cells for cancer immunotherapy: Siglec-7/9/10/15 and their ligands
5. Dysregulation of developmental and cell type-specific expression of glycoconjugates on hematopoietic cells: a new characteristic of myelodysplastic neoplasms (MDS)
6. Sialic acid–modified der p 2 allergen exerts immunomodulatory effects on human PBMCs
7. Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions
8. Limited impact of cancer-derived gangliosides on anti-tumor immunity in colorectal cancer
9. In‐depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations
10. Deciphering the Chemical Language of the Immunomodulatory Properties of Veillonella parvula Lipopolysaccharide
11. Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits
12. Uptake Kinetics Of Liposomal Formulations of Differing Charge Influences Development of in Vivo Dendritic Cell Immunotherapy
13. Selective tumor antigen vaccine delivery to human CD169+ antigen-presenting cells using ganglioside-liposomes
14. The immunological landscape of peripheral blood in glioblastoma patients and immunological consequences of age and dexamethasone treatment
15. The sialic acid-Siglec immune checkpoint: an opportunity to enhance immune responses and therapy effectiveness in melanoma
16. Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin
17. Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity
18. Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells.
19. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
20. Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses
21. Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer
22. Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells
23. Human C-Type Lectins, MGL, DC-SIGN and Langerin, Their Interactions With Endogenous and Exogenous Ligand Patterns
24. Immobilization of β-galactosidase and α-mannosidase onto magnetic nanoparticles: A strategy for increasing the potentiality of valuable glycomic tools for glycosylation analysis and biological role determination of glycoconjugates
25. Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses.
26. Two Distinct Cytoplasmic Regions of the β 2 Integrin Chain Regulate RhoA Function during Phagocytosis
27. Synergistic effects of dendritic cell targeting and laser-microporation on enhancing epicutaneous skin vaccination efficacy
28. Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection
29. The Small GTPase, Rap1, Mediates CD31-Induced Integrin Adhesion
30. Next-generation malarial vaccines
31. DC-SIGN. C-Type Lectin with Prominent Role in Immune System
32. Simple engineering of hybrid cellulose nanocrystal-gold nanoparticles results in a functional glyconanomaterial with biomolecular recognition properties
33. Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells
34. Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
35. MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses
36. Macrophage galactose-type lectin (MGL) is induced on M2 microglia and participates in the resolution phase of autoimmune neuroinflammation
37. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens
38. Novel insights into the immunomodulatory role of the dendritic cell and macrophage-expressed C-type lectin MGL
39. Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
40. The transcriptional landscape of glycosylation-related genes in cancer
41. Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment
42. Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells
43. Antigen-Presenting Cells in the Central Nervous System
44. Notch controls generation and function of human effector CD8+ T cells
45. Optimization of liposomes for antigen targeting to splenic cd169+ macrophages
46. Targeting tumor antigens to dendritic cells using particulate carriers
47. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
48. Specific glycan elements determine differential binding of individual egg glycoproteins of the human parasite Schistosoma mansoni by host C-type lectin receptors
49. Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses
50. S Layer Protein A of Lactobacillus acidophilus NCFM Regulates Immature Dendritic Cell and T Cell Functions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.